Published in Obesity and Diabetes Week, September 22nd, 2003
The financing was co-led by a previous investor, Bay City Capital, and new investors Biotech Turnaround Fund, BV, and CDP Capital Technology Ventures. Other participants in the financing included previous investor Charter Ventures and new investor KBC. CIBC World Markets was the agent for this financing.
"We are pleased to close this significant financing, which gives us the resources to move forward energetically toward building the leading drug development...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.